Key facts
- Xi'an MicroPace MedTech’s last known valuation is $44.4M (Jan 2025).
- It has raised $12.4M; the latest was Later Stage VC ($5.5M) in Jan 2025.
- Notable investors include Qiming Venture Partners, Proxima Ventures (China), Xinke Capital, TigerYeah Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Xi'an MicroPace MedTech
- ·The full record, as it builds
Funding rounds
No funding rounds for Xi'an MicroPace MedTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xi'an MicroPace MedTech
Developer and manufacturer of high-end medical devices based in Xi'an, China. The company develops and manufactures medical devices such as leadless pacemaker, neurostimulator, and defibrillator, committing to improving heart disease treatment.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2018
- Employees
- 9
- Ownership
- Privately Held (backing)
Xi'an MicroPace MedTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xi'an MicroPace MedTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xi'an MicroPace MedTech in its N-PORT filings yet. We sweep new filings monthly.